Radiology artificial intelligence (AI) software developer Quantib has released upgrades to its Quantib ND dementia and multiple sclerosis (MS) diagnosis software.
Designed to provide objective tracking of disease development, the software can now help clinicians to quantify brain atrophy and white-matter hyperintensities, as well as changes in the brain related to dementia and MS, the company said. It also includes graph tools that provide information on expected brain volume at particular patient ages.
Quantib ND has received the CE Mark and is available throughout Europe, according to the firm.
